Achillion Pharma (ACHN) Reports Q4 Loss of $0.12/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mail
Get Alerts ACHN Hot Sheet
Join SI Premium – FREE
Achillion Pharma (NASDAQ: ACHN) reported Q4 EPS of ($0.12), versus ($0.17) reported last year. Revenue for the quarter came in at $12.2 million, versus $15.4 million reported last year.
For earnings history and earnings-related data on Achillion Pharma (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
- SpaceX's spectrum deal puts SIRI's satellite assets in focus
- HIMS jumps 7% on peptide tailwind but Citi sees 17% downside from here
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
